Cite
HARVARD Citation
Zhu, R. et al. (2019). Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer. CPT: pharmacometrics & systems pharmacology. pp. 240-248. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhu, R. et al. (2019). Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer. CPT: pharmacometrics & systems pharmacology. pp. 240-248. [Online].